Abstract P5-16-27: Variation in the use of neoadjuvant chemotherapy for breast cancer in the Netherlands. A lack of consensus
Conclusions: Stromal FAPα in residual cancer after NC is higher in TN breast cancer but without association with relapses in our small sample. However, in luminal B subtype stromal FAPα is smaller in pts with relapses.Citation Format: Spronk PER, Bommel van ACM, Siesling S, Vrancken Peeters M-JT, Smorenburg CM. Variation in the use of neoadjuvant chemotherapy for breast cancer in the Netherlands. A lack of consensus [abstract]. In: Proceedings of the Thirty-Ninth Annual CTRC-AACR San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-16-27.
Source: Cancer Research - Category: Cancer & Oncology Authors: PER Spronk, ACM Bommel van, S Siesling, M-JT Vrancken Peeters, CM Smorenburg Tags: Poster Session Abstracts Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Epithelial Cancer | HER2 | Herceptin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy